Solstice Advanced Materials heads into its August 5 earnings event carrying a short interest position that has nearly tripled in a month — while the stock itself has shed a third of its value over the same period.
The dominant story this week is the speed and scale of the short rebuild. Short interest has risen 76% over the past week to 6.2% of free float — and that figure is up 147% from a month ago. To put that in perspective: shorts held roughly 5.4 million shares in late June; they now hold nearly 9.9 million. What makes this particularly striking is that the borrow market is barely registering the pressure. Availability is extremely loose at over 4,000% — meaning roughly 80 million shares remain available to borrow against the current short position, making it trivially easy to build new positions. Cost to borrow is just 0.35%, a level consistent with a stock where bearish conviction costs almost nothing to express. The ORTEX short score jumped from the low 30s to above 43 in the span of a single week, then eased slightly to 41.4 — a rapid re-rating that tracks almost perfectly with the doubling of the short position around July 24.
The options market adds a further defensive layer. The put/call ratio is running at 1.23, modestly above its 20-day average of 1.17, with a z-score of 0.39 — not extreme, but reinforcing a bias toward downside hedging that has been building since late June, when the PCR was below 0.30. The shift from a ratio near 0.30 to above 1.20 over five weeks is a meaningful rotation: participants who were leaning bullish through calls have progressively added put protection as the stock gave up ground.
The valuation backdrop reflects the same slide. The P/E ratio has compressed nearly 34% over the past month to 18.7x, while price-to-book is down roughly 35% over the same stretch to 4.4x. The stock now trades at $60.15, down 32% on the month but up 4.8% on Friday, suggesting some positioning reset ahead of the event. The EV/EBITDA of 10.1x is broadly stable. Among close peers, TROX is the worst performer this week at -6.4%, while ESI slipped 1.9%; neither move offers SOLS a clear read-across, though the broader specialty chemicals complex has been under pressure.
The most recent earnings event on record — a print in late July — produced a 1-day move of 8.1%. The May print delivered a 6.6% day-one gain and a 6.1% five-day follow-through. Both were positive reactions, which sits in mild tension with the bearish repositioning visible in the short data this month. Whether that divergence reflects a view that the macro or product-cycle backdrop has deteriorated since May, or simply reflects hedging ahead of a volatile print, is the question the August 5 release will resolve.
The setup into next week is therefore less about whether SOLS can beat — it has done so twice in a row — and more about whether shorts who built aggressively into the 30%-plus drawdown treat any earnings beat as a catalyst to cover or choose to hold through what has historically been a volatile post-print window.
See the live data behind this article on ORTEX.
Open SOLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
